Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033

BACKGROUND: EORTC study 22033–26033 showed no difference in progression-free survival between high-risk low-grade glioma receiving either radiotherapy (RT) or temozolomide (TMZ) chemotherapy alone as primary treatment. Considering the potential long-term deleterious impact of RT on memory functionin...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Martin, Drijver, A Josephine, van den Bent, Martin J, Bromberg, Jacolien C, Hoang-Xuan, Khê, Taphoorn, Martin J B, Reijneveld, Jaap C, Ben Hassel, Mohamed, Vauleon, Elodie, Eekers, Daniëlle B P, Tzuk-Shina, Tzahala, Lucas, Anna, Freixa, Salvador Villà, Golfinopoulos, Vasilis, Gorlia, Thierry, Hottinger, Andreas F, Stupp, Roger, Baumert, Brigitta G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099470/
https://www.ncbi.nlm.nih.gov/pubmed/33130890
http://dx.doi.org/10.1093/neuonc/noaa252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099470/
https://www.ncbi.nlm.nih.gov/pubmed/33130890
http://dx.doi.org/10.1093/neuonc/noaa252

Ejemplares similares